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Abstract
Acetaminophen (paracetamol) is available in a wide range of oral formulations de‐
signed to meet the needs of the population across the age-spectrum, but for people
with impaired swallowing, i.e. dysphagia, both solid and liquid medications can be
difficult to swallow without modification. The effect of a commercial polysaccharide
thickener, designed to be added to fluids to promote safe swallowing by dysphagic
patients, on rheology and acetaminophen dissolution was tested using crushed im‐
mediate-release tablets in water, effervescent tablets in water, elixir and suspension.
The inclusion of the thickener, comprised of xanthan gum and maltodextrin, had a considerable impact on dissolution; acet‐
aminophen release from modified medications reached 12-50% in 30 minutes, which did not reflect the pharmacopeia
specification for immediate release preparations. Flow curves reflect the high zero-shear viscosity and the apparent yield
stress of the thickened products. The weak gel nature, in combination with high G’ values compared to G” (viscoelasticity)
and high apparent yield stress, impact drug release. The restriction on drug release from these formulations is not influenced
by the theoretical state of the drug (dissolved or dispersed), and the approach typically used in clinical practice (mixing
crushed tablets into pre-prepared thickened fluid) cannot be improved by altering the order of incorporation or mixing method.
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 Abstract  
Acetaminophen (paracetamol) is available in a wide range of oral formulations designed to 
meet the needs of the population across the age-spectrum, but for people with impaired 
swallowing, i.e. dysphagia, both solid and liquid medications can be difficult to swallow 
without modification. The effect of a commercial polysaccharide thickener, designed to be 
added to fluids to promote safe swallowing by dysphagic patients, on rheology and 
acetaminophen dissolution was tested using crushed immediate-release tablets in water, 
effervescent tablets in water, elixir and suspension. The inclusion of the thickener, comprised 
of xanthan gum and maltodextrin, had a considerable impact on dissolution; acetaminophen 
release from modified medications reached 12-50% in 30 minutes, which did not reflect the 
pharmacopeia specification for immediate release preparations. Flow curves reflect the high 
zero-shear viscosity and the apparent yield stress of the thickened products. The weak gel 
nature, in combination with high G’ values compared to G” (viscoelasticity) and high 
apparent yield stress, impact drug release. The restriction on drug release from these 
formulations is not influenced by the theoretical state of the drug (dissolved or dispersed), 
and the approach typically used in clinical practice (mixing crushed tablets into pre-prepared 
thickened fluid) cannot be improved by altering the order of incorporation or mixing method.   
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 Introduction 
The range of oral dosage forms available, from solids such as tablets and capsules through to 
liquids such as elixirs and suspensions, are designed to address the therapeutic needs of the 
majority of the population including infants, adults and the elderly. However, patients with 
impaired ability to swallow (i.e. dysphagia) vary in their ability to swallow food and fluids 
without aspiration into the airways (1). Whole tablets and capsules should be avoided for 
people with swallowing impairments due to the risk of aspiration and penetration into the 
airway (2). Oral liquid dose forms represent an alternative to the use of solid dose forms for 
people with swallowing issues, but thin fluids leave dysphagic patients at risk of aspiration as 
a consequence of the poor control of liquids. In the absence of alternatives, the most common 
solution to the medication delivery dilemma for dysphagic patients is to crush tablets and 
open capsules, and mix the powder with food (3, 4), thickened fluid or naturally thick food 
vehicles such as yoghurt, jam, or pudding (5-7). The use of thickeners to facilitate safe 
swallowing of fluids is a result of the rheological properties of these agents (8) as the 
increased viscosity of the fluid leads to better control over the timing of opening of the valves 
involved in swallowing, reducing the chance of transit straight into the airway (9). 
Previous research has demonstrated that water thickened with commercial polysaccharide 
thickeners, has the potential to negatively impact the release of conventional crushed tablets 
when they are used in replacement of water. The effects were thickener and viscosity-
dependent, with products containing xanthan gum and higher thicknesses causing the greatest 
restriction in drug release (10).  
The aim of this research is to determine whether the state of drug aggregation within the 
thickened water (i.e. dissolved or dispersed) is an important determinant of drug release. 
Acetaminophen (paracetamol) is a good example of an active ingredient available in several 
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 solid and liquid oral formulations. Acetaminophen tablets are the most commonly modified 
medicine for adults and children in Australian hospitals (5) and most commonly cited as 
being difficult to swallow (11). It is available in dosage forms that provide paracetamol in 
solution (syrup and dissolved effervescent tablets) and dispersed state (suspension, crushed 
immediate release tablets in water). The hypothesis to be tested is that the limitation on drug 
release is reduced when the acetaminophen is dissolved rather than dispersed within the 
thickened water. Two approaches can be applied to test this hypothesis, firstly to vary the 
order of adding the components to allow acetaminophento dissolve in water and then mix into 
thickened water, as opposed to the standard clinical practice of dispersing crushed tablet 
powder into pre-thickened water. The second approach is to compare the effect on drug 
release of thickening commercial products that have acetaminophen dissolved (effervescent 
tablet, elixir) or dispersed (suspension). Additionally, detailed rheological characterisation of 
the thickened products was carried out to consider the contribution of viscoelasticity and 
yield stress to restriction on drug release. 
Material and methods 
Materials  
The dosage forms studied were available in Australia in 2012 when this work was conducted: 
Panadol immediate release tablets 500 mg, round and film coated (marketed in Australia with 
statements declaring these forms do not have any ingredient that improves absorption), 
Panadol rapid soluble effervescent tablets 500 mg, Panadol children’s 5-12 years raspberry 
flavour elixir (48 mg/mL), and Panadol children’s 5-12 years colour free orange flavour 
suspension (48 mg/mL). Deionized water or deionized water thickened with Easythick 
(Flavour Creations, Brisbane, Australia) was used as the drug delivery vehicle. Easythick 
(contents: maltodextrin, xanthan gum, sodium chloride) was prepared using the quantity 
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 indicated by the manufacturer to produce the thickest level described by the Australian 
National Standards for dysphagic patients (12, 13), level 900, which indicates that the 
apparent viscosity at a shear rate of 50
-1
 should be greater than 900 mPas. Spoon 
measurements of the thickener were converted to weight to provide the desired percentage 
(%w/v). To produce thickened water at level 900, each 185 mL of water required 5 teaspoons 
of the thickener, equivalent to 13.5 g (7.3% w/v), so for 15 mL of water 1.1 g of thickener 
was added. 
Experimental design  
The role in drug release of the method used to incorporate crushed tablets into the thickened 
water was investigated by varying both the order of addition of the three components, 
crushed tablet, water, and thickener powder, and the technique used to add the medication 
(manually with a spatula versus mechanical high speed stirrer). The variations in the order of 
addition were: 
 Variant 1: thickener + water, then crushed tablet (i.e. the water was thickened before 
the crushed tablet was mixed in) 
 Variant 2: crushed tablet + water, then thickener (i.e. the crushed acetaminophen 
tablet was suspended in the water before the water was thickened) 
 Variant 3: crushed tablet + thickener, then water (i.e. the crushed tablet was mixed 
with the thickener powder before the water was thickened) 
Additionally, the potential to thicken commercially available liquid dosage forms was 
investigated using acetaminophen in solution (i.e. effervescent tablet, elixir) and suspension. 
The entire experiment was replicated three times.  
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 Sample preparation  
Preparation of solid formulations by manual incorporation  
For variant 1, which represents standard clinical practice (5-7), one immediate release 
acetaminophen tablet was crushed in a mortar and pestle and the contents transferred to a 30 
mL disposable plastic cup. Thickened water was prepared by adding 3.6 g of thickener 
powder to 50 mL water and mixed with a hand stick blender (Tiffany 200W) with stainless 
steel shaft at stirring level 2 for one minute until a uniform mass was formed, then 15 g of 
this thickened water was added to the cup containing one crushed tablet and manually mixed 
with a metallic spatula for 3 minutes.  
For variant 2, one acetaminophen tablet was crushed and transferred to weighing paper, then 
to a 30 mL disposable cup. The mortar and pestle and weighing paper were rinsed with 10 
mL and 5 mL (15 mL total) of deionized water and added into the cup. 1.1 g thickener 
powder was gradually incorporated and stirred until homogeneous.  
For variant 3, one acetaminophen tablet was crushed and transferred to weighing paper, then 
to a 30 mL disposable cup. 1.1 g of thickener powder was added to the cup containing the 
crushed tablet and stirred. Then the mortar and pestle and weighing paper were rinsed with 10 
mL and 5 mL (15 mL total) of deionized water and added into the cup and mixed.  
All samples were manually mixed with a stainless steel spatula for five minutes until the 
mixture was visually homogeneous. To allow full hydration and swelling, after the thickener 
and water were mixed, samples were covered with a double layer of Parafilm
®
 M (Sigma-
Aldrich, Pty. Ltd. Sydney, Australia) and kept at 4°C overnight prior to dissolution testing; 
once swelling is complete, gum-based thickeners do not change viscosity (14). For variant 3, 
the thickened water prepared overnight was manually mixed with the crushed tablet 15 
minutes before dissolution testing. 
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 Weights of the intact tablet, mortar and pestle with and without residuals, empty disposable 
cup and disposable cup with crushed contents were noted.  
Preparation of solid formulations by mechanical incorporation 
In order to use an overhead stirrer for mechanical incorporation, the quantity prepared was 
up-scaled to produce an appropriate volume. Three and half acetaminophen tablets were 
crushed in a mortar and pestle and the solid transferred into a 100 mL glass beaker.  
For variant 1, thickened water was prepared by adding 3.6 g of thickener powder to 50 mL of 
deionized water in a measuring cylinder and mixed.  
For variant 2, 50 mL water was added to the beaker containing crushed tablets, and then 3.6 g 
thickener powder was added and mixed.  
For variant 3, 3.6 g thickener powder was added to the beaker containing crushed tablets, and 
then a volume of 50 mL of water was added and mixed.  
All the samples were mixed using an IKA® RW20 digital overhead stirrer, with a crossed 
blade impellor (Thermo Fisher Scientific Australia Pty Ltd, Scoresby, Australia) at 400 rpm 
for five minutes. For the purpose of de-aeration, 30 g of mechanically mixed samples and 
thickened water used in variant 1 were transferred to 50 mL centrifuge tubes and centrifuged 
(Eppendorf Centrifuge 5804 R, VWR International, Pty Ltd, Brisbane, Australia) at 2000 rpm 
for two minutes at 20°C. These were then covered with a double layer of Parafilm® M kept 
at 4°C overnight prior to dissolution testing to allow full hydration and swelling. For variant 
1, the thickened water was recombined in a glass beaker after removal from refrigerated 
storage and mixed with the crushed tablets. 15 g of samples (equivalent to 1 crushed tablet) 
were weighed into a 30 mL disposable plastic cup 15 minutes before dissolution testing.  
Weights of the intact tablet, mortar and pestle with and without residuals, empty disposable 
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 cup and disposable cup with crushed contents were noted. 
Preparation of liquid formulations  
The quantity of thickener added to liquid formulations was the quantity required to thicken 
water to level 900. A dose of 15 mL of elixir or suspension formulations were measured, 
placed into a 30 mL disposable plastic cup, and 1.1 g of thickener powder was added and 
mixed with a stainless steel spatula for 5 minutes to ensure the thickener was well dispersed. 
One effervescent tablet was dissolved in 100 mL water, and 7.3 g of thickener powder was 
added and mixed until a thick solution free of powder was formed. Thickened samples were 
covered with a double layer of Parafilm® M and kept at 4°C overnight.  
Methods  
Drug release and dissolution 
For the dissolution studies, prepared samples were removed from refrigeration and allowed to 
sit at room temperature for 15 minutes prior to starting dissolution testing. The samples were 
tested using USP dissolution apparatus II (VK7000, Varian, Mulgrave, Vic) with 900 mL of 
simulated gastric fluid (SGF) pH 1.2 without enzymes (15) at 37°C and paddle speed of 50 
rpm. 3 mL samples were collected at 1, 3, 5, 10, 25, 30, 60, 90, 120, 150, 180 minutes 
through stainless steel cannula assembled with flow filter (10 μm, Varian) into 3 mL plastic 
syringes and 3 mL of fresh SGF was added at every sampling point (16). In this study we 
used one dissolution environment to allow direct comparison of multiple dosage forms.  
Samples were filtered through 0.45 μm nylon membranes (Grace Davison Discovery 
Sciences, Alltech Associates Pty Ltd Vic) and diluted to obtain the desired concentrations to 
enable readings using UV spectroscopy. A calibration curve was constructed and the 
absorbance of acetaminophen samples was measured at 244 nm Hitachi U-1900 
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 Spectrophotometer, (Hitachi Australia Pty, Ltd, Sydney, Australia). Whole tablet in 15 mL 
water, crushed tablet in 15 mL water (dispersed by agitation with a metallic spatula), the 
elixir, suspension and dissolved effervescent medications without thickener were performed 
for comparison. Thickened water without medication was measured as control. To account 
for background absorbance associated with the thickener, absorbance readings for the control 
(always < 0.015) were subtracted from the absorbance of the samples containing drug. 
Cumulative dissolution of acetaminophen was plotted against time and analysed for 
differences in dissolution at 30 minutes with one way ANOVA (P<0.05) and a Bonferroni 
post hoc test using GraphPad Prism version 6 (GraphPad software, San Diego, CA, USA); all 
data tested complied with the assumptions of ANOVA for normality and equality of variance  
The Korsmeyer-Peppas model was fitted to the cumulative release versus time plots using 
SigmaPlot 12.0 (Systat Software, Inc. San Jose, CA, USA). The Korsmeyer-Peppas is an 
empirical equation that correlates the amount of the drug released (𝑀𝑡) and the exponential 
function of the release profile: 
𝑀𝑡/𝑀∞  =  𝑘𝑡
𝑛   Equation (1) 
where 𝑀𝑡 is the amount of drug release at time 𝑡, 𝑀∞ is the total drug released over the 
duration of the experiment, 𝑘 is the kinetic constant, and 𝑛 is the release exponent (17). 
Cumulative release profiles were compared using the similarity factor, f2 (18). 
Rheological measurements 
Samples were prepared following the same conditions and at the same time as for dissolution 
testing. Rheological attributes of the elixir and dissolved effervescent tablet without thickener 
were measured in a stress controlled rheometer G2 (TA instruments C/O Waters Australia, 
Pty, Ltd, Sydney, Australia) using cone and plate titanium 40 mm, 2 deg, 63 μm truncation 
attachment at 37°C. Samples were equilibrated for 2 minutes prior to measuring. The cone 
JU
ST
AC
CE
PT
ED
 and plate was used to give constant shear rate throughout the sample so the viscosity does not 
vary within the geometry. Thickened samples were also measured in the cone and plate, but 
for several measurements artefacts arose including slip, and confinement of undissolved 
particulates from the comminuted tablets; such phenomena are described in detail by Davis 
and Stokes (19). To overcome these particular issues, a vane-in-cup geometry was used, 
which is appropriate to characterise the rheology of structured fluids with characteristics of a 
weak gel that contains yield stress, as described in Stokes and Telford (20). Thickened water, 
suspension, thickened liquid dosage forms and one crushed tablet manually mixed into 
thickened water (variant 1) were prepared, equilibrated at 37°C for 30 minutes and the 
measurements taken in a AR 1500ex stress controlled rheometer (TA instruments C/O Waters 
Australia, Pty, Ltd, Sydney, Australia) with a large aluminium vane at 37°C. The linear 
viscoelasticity of the samples were characterised using small amplitude oscillatory testing: 
the viscous (loss modulus, G”) and elastic properties (storage modulus, G’) were obtained as 
a function of frequency. Small oscillatory measurements were carried out on the prepared 
samples. Stress sweep tests were first performed from 0.1 to 100 Pa, with 1 Hz frequency 
value at 37°C, to determine the linear viscoelastic region. The stress was linear with strain 
across a brand frequency range at 1 Pa and therefore frequency sweep tests were performed 
from 10.0 to 0.1 Hz, with 1 Pa constant stress at 37°C.   
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 Results  
Based on the weight of powder contained in the cups prior to mixing with thickened water 
and assuming that 100% corresponded to 500 mg of the content declared in one tablet, 
between 3% to 4% of drug was lost during the crushing, weighing, and transfer into the cups 
with no difference between method variants. This loss has not been accounted for in the 
results, but indicates that the total % dissolution that could be obtained from the crushed 
tablets could reach a maximum of 96 to 97%. 
Dissolution experiments 
Acetaminophen is classified in the Biopharmaceutical Scheme as BCS class III, but possesses 
some attributes of the BCS class I substances (21). Its solubility is not pH dependent within 
physiological range, having a pKa value of 9.5, so adjusting the dissolution media pH used in 
this study would not be expected to affect dissolution. Acetaminophen whole and crushed 
tablets delivered with water exhibited rapid and complete dissolution in SGF with over 96% 
of the drug released and measured in the first 30 minutes (Fig. 1A, Table 1). Similarly, 
acetaminophen was immediately released from the elixir and the effervescent tablet (Fig. 
2A,B, Table 2). In contrast, the suspension exhibited moderate release under the conditions of 
this dissolution test, with only 30% released in 30 minutes (Fig. 2C, Table 2). 
Modified solid dosage forms 
Using crushed tablets, the effect of the state of drug aggregation (dissolved or dispersed), the 
order of adding components, and mixing method were investigated. The standard clinical 
method of preparation, in which crushed tablets were mixed into 15 g of pre-thickened water 
(variant 1), resulted in only 36% acetaminophen being dissolved in the first 30 minutes 
(Table 1). Thickener slowed dissolution for all formulations involving crushed tablets, 
irrespective of whether manual or mechanical mixing was used or the order of incorporation 
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 of the components (Fig. 1B,C, Table 1). The manual mixing method produced formulations 
with faster release of acetaminophen than mechanical mixing (P < 0.001) with differences of 
9.5%, 15.2% and 13.7% at 30 minutes for variants 1, 2 and 3 respectively (Table 1). 
The dissolution profiles for the crushed tablets in thickened fluid were compared to the intact 
dosage form by the similarity factor f2 (18). All medications delivered with thickened water 
invariably resulted in f2 of less than 50 (Table 1) which confirms that the dissolution profiles 
were dissimilar and predicts that differences are likely to occur in vivo. The Korsmeyer-
Peppas model fitted the dissolution profiles well (r
2
 = 0.98-0.99; Table 1). The release 
exponent n was 0.41 to 0.49, indicating primarily Fickian diffusion-controlled release. 
Modified liquid dosage forms 
The quantity of thickener required to thicken water to level 900 was added to acetaminophen 
elixir, dissolved effervescent tablet and suspension, resulting in a significant change in 
dissolution profile in comparison to the unthickened products. The quantity of acetaminophen 
dissolved at 30 minutes was reduced for all three formulations, with differences caused by 
addition of thickener of 52%, 86% and 22% for the effervescent tablet, elixir and suspension 
respectively (Fig. 2). The similarity factor f2 was estimated for each modified medication with 
respect to its intact dosage form, and in all cases f2 was lower than 50 which confirmed lack 
of similarity. 
The Korsmeyer-Peppas model was fitted to the dissolution profiles (r
2
= 0.97-0.99; Table 2) 
except the unthickened effervescent tablet and unthickened elixir because the acetaminophen 
was already in solution in these formulations before the dissolution test started. The release 
exponent n was close to 0.5, indicating primarily Fickian diffusion-controlled release, though 
it varied to a greater extent for the thickened liquid formulations (0.34 to 0.58) than the 
thickened crushed tablet formulations (0.41 to 0.49).  
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 Rheology of the thickened medications  
All samples containing thickener exhibited non-Newtonian shear-thinning behavior with 
viscosity values dependent on the shear stress applied to the sample (Fig. 3). Unthickened 
acetaminophen suspension also exhibited non-Newtonian behavior, reflecting the structured 
vehicle contained in the suspension. The viscosity of the elixir and dissolved effervescent 
tablet were very low and similar to water and remained invariable with stress (data not 
shown), typical of Newtonian behavior.  
A shear rate of 50 s
-1
 was chosen for comparison as it is commonly used in evaluation of fluid 
foods as an indicator of the dominant shear rate operating in the oral cavity (22) and is the 
shear rate used for the number category system for texture-modified fluids in the US and 
Australia (23). The elixir and effervescent tablet with no thickener exhibited low viscosity of 
15 mPas and 8 mPas (Table 3). Water thickened to level 900 was indeed characteristic of its 
texture-modified fluid category with a viscosity of 917 mPas, while addition of a crushed 
tablet to the thickened water reduced viscosity to 625 mPas but addition of thickener to the 
effervescent tablet in water increased viscosity to 1540 mPas, presumably associated with 
different excipients contained in the immediate release and effervescent tablets. With a 
viscosity of 403 mPas, the suspension may be categorized as level 400, but addition of 
thickener resulted in a very thick liquid (4380 mPas); the thickened elixir was also very thick 
(3650 mPas) despite the primary formulation having very low viscosity and Newtonian 
behavior.  
Relative differences between formulations (Table 3) in zero-shear viscosity (i.e. at very low 
shear rate, <1 Pa) and infinite-shear viscosity values (i.e. at high shear stress >100 Pa) largely 
echoed the relationships observed in viscosity at 50 s
-1
, except that the crushed immediate 
release tablet in thickened water was more similar to the effervescent tablet in thickened 
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 water at low and high shear stresses . The apparent yield stress, which is the stress value at 
which viscosity decreases by several orders of magnitude so flow occurs (24), also 
highlighted the greater resistance to flow of the thickened suspension (39 Pa) in comparison 
to the other thickened formulations (17-26 Pa) and the unthickened suspension (2.7 Pa) 
(Table 3). 
The thickened formulations were semi-solid in appearance. The mechanical spectra were 
obtained and the results expressed in terms of an elastic storage modulus (G’) and viscous 
loss modulus (G”) (Fig. 4). The thickened samples and the unthickened suspension all 
behaved as viscoelastic solids with G’ dominating over G” across a substantial frequency (𝑣) 
range (cycles/sec). Thickened effervescent tablet and crushed tablet in thickener were very 
similar in response to the thickened water alone. As defined by Stokes, a weak gel is a 
substantially diluted system that displays a solid-like behavior but is also able to exhibit 
steady state flow (24). As these fluids flow above an apparent yield stress, they are referred to 
here as weak gels. 
Discussion 
The presence of thickened fluid, irrespective of the dosage form or the method of preparation, 
had a substantial impact on in vitro drug dissolution. The extent of the effect depended upon 
the aggregation state of the drug contained in the dosage form and on other components of 
the dosage form. It is well known that increasing dissolution media viscosity retards release 
by increasing disintegration and dissolution time (25, 26) but that was not the reason for the 
delayed dissolution in this case because 15 g of thickened fluid does not appreciably increase 
the viscosity of 900 mL of SGF (10). 
Method variant 1 with manual mixing was designed to be most similar to typical clinical 
practice, in which thickened fluid is prepared and then a crushed tablet is added into it and 
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 mixed with a spatula or spoon. This standard method resulted in acetaminophen dissolution 
being only 36% by 30 minutes, with a dissimilar release profile (f2<50) to that of the whole 
tablet. The amount of drug measured in a dissolution test for immediate release tablets should 
be not less than 85% of the labeled amount within 30 minutes according to FDA guidance 
information for immediate release solid forms (27), however, acetaminophen dissolution did 
not reach this level even at 3 hours. Importantly, since only 3-4% was lost during crushing 
and transfer, some acetaminophen was still entrapped within the thickened fluid. 
No improvement in acetaminophen release and dissolution were gained by altering the 
method of preparation. For instance, mixing the tablet powder with water first, to suspend 
and partially dissolve the acetaminophen prior to adding the thickener powder (variant 2) did 
not affect acetaminophen dissolution. The only alteration in dissolution was caused by using 
mechanical instead of manual mixing, causing a significant reduction in dissolution. The 
treatment of the samples after preparation using the mechanical mixer (i.e. air elimination by 
centrifugation, required to stop the thickened fluid chunks from floating in the dissolution 
chamber) may have been associated with the increased entrapment of the drug.  
The use of commercial liquid dosage forms was investigated as a potential alternative to 
crushed tablets for delivery of a thickened oral medication dose. Acetaminophen effervescent 
tablets dissolved in water and acetaminophen elixir were low-viscosity products (ƞ50 < 15 
mPas) in which acetaminophen was present in solution. These reached 100% dissolution 
immediately on addition to the test vessel. Adding thickener to these formulations increased 
their viscosity, which negatively impacted the rate and extent of drug release into the media. 
The viscosity of these thickened formulations was higher than thickened water (ƞ50 = 917 
mPas), and the elixir (ƞ50 = 3650 mPas) was more strongly affected than the effervescent 
tablet in water (ƞ50 = 1570 mPas), indicating that the excipients within the different 
formulations interacted with the thickener to influence viscosity.  
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 In the acetaminophen suspension, the drug is expected to be dispersed and partially dissolved 
in the structured vehicle (ƞ50 = 403 mPas), so not surprisingly, dissolution was slower than 
for acetaminophen in solution with only 30% dissolving within 30 minutes. In fact the 
suspension only reached 85% dissolution after 2 hours of the test, with a profile that was 
more similar to the crushed tablet in thickened fluid (f2 = 60) than the whole tablet (f2<50). 
Slow release of acetaminophen from a commercial suspension has also been measured using 
a flow through cell with and without a dialysis adapter, with 40-60% being released in 30 
minutes (28). Addition of thickener reduced release further, producing a dissolution curve 
that was very similar to that of the thickened elixir even though the viscosity of the thickened 
suspension was much higher (ƞ50 = 4380 mPas). Adding the thickener increased the 
complexity of the microstructure, increasing the zero-shear and infinite-shear viscosity as 
well as apparent yield stress to the highest values of all of the thickened formulations.  
The results suggest that the weak gel nature of the formulations and rheological variables 
have a substantial effect on drug dissolution and release into SGF. The products with the 
highest elastic modulus (G’), i.e. greater solid-like behaviour, were associated with the 
greatest restriction on acetaminophen release. Similarly, formulations with higher apparent 
yield stress values, i.e. requirement for a higher shear stress to break the structure and cause it 
to flow, exhibited slowest dissolution profiles. Rheological parameters, such as apparent yield 
stress, control breakup of the swallowed bolus and its flow behaviour along the 
gastrointestinal tract. The high yield stress values for the thickened elixir (26 Pa) and 
thickened suspension (39 Pa) are both values that exceed the maximum range indicated for 
the thickest fluids (14-21 Pa) according to the Australian Fluid Level Standards (13). With 
such high yield stress values it is possible that shear forces in the stomach are sufficient to 
only partially shear the samples, as computer simulations indicate that shear forces are only 
JU
ST
 AC
CE
PT
ED
 10-30 Pa in the antrum and <1 Pa in the fundus (29, 30). This is expected to impact on drug 
release and therefore availability for absorption.  
There are multiple factors not tested in this study that could alter drug release from the 
thickened fluids and cause release in vivo to be faster and/or greater than that obtained here, 
for example the fasted or fed state determines enzyme activity in the mouth and 
gastrointestinal tract and may cause preliminary breakdown of the bolus (31), and peristaltic 
mixing, gastric emptying and gastrointestinal transit time are expected to be important 
determinants of bolus integrity (32). The thickening agent itself is also an important 
consideration. Previous studies have demonstrated that increased viscosity, regardless of the 
thickening agent used, impedes drug release in in vitro studies (10). However, certain 
attributes may predispose some thickening agents to be better suited for drug delivery than 
others. For example, starch based thickening agents will be heavily dependent on amylase in 
the oral cavity and small intestine (33) whereas xanthan gum breaks down as a result of 
interactions with gut bacteria in the lower intestinal tract (34).  
It is not clear from the results whether the delay in dissolution is due to restriction on 
dissolution within the thickener and/or diffusion out of the thickener. On one hand, 
improvement in release occurred when the acetaminophen was in solution within the 
thickener, as for the dissolved effervescent tablet (50% at 30 mins) in comparison to being 
dispersed in the thickener as for the crushed tablet (36% at 30 mins). This may be taken to 
indicate that release was slower if the drug powder had to dissolve prior to diffusing. On the 
other hand, the thickened elixir and thickened suspension exhibited the same dissolution 
profile but the acetaminophen was presumed to be in solution in the elixir but dispersed in the 
suspension. However, these comparisons are complicated by the different dosage forms and 
associated excipients involved. For example guar gum viscosity is increased by polyols (35) 
such as those present in the elixir (sorbitol) and suspension (maltitol and sorbitol), so similar 
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 effects are anticipated with xanthan gum. Furthermore, the quantity of thickener added to 
each formulation was calculated for use in water, so reducing the quantity added to account 
for the composition of the dispersing media would be required for complex formulations such 
as this (8, 36, 37).  
Conclusions 
This study demonstrated that dissolution is affected by the presence of thickeners added to 
facilitate oral ingestion of medicines. Drug release from thickened medications was 
unaffected by the state of aggregation of the drug e.g. dissolved in the thickened elixir and 
effervescent tablet and dispersed in the thickened suspension. Each dosage form has the 
potential to respond in a different manner to the addition of thickening agents due the 
presence of excipients. This has implications for the therapeutic effect of the drug when given 
in this manner. The typical clinical practice approach of preparing the thickening agent and 
then adding the crushed medication with manual stirring was not improved by altering the 
order of addition or mixing method. The rheology of the thickened products indicated that the 
weak gel structures of the formulations considerably impacted drug dissolution and release 
into SGF so the greatest viscoelasticity and apparent yield stress values exhibited the slowest 
and most restricted dissolution. The results of the current study indicate that in vivo trials are 
warranted. 
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 Figure 1. 
Dissolution of whole and crushed acetaminophen tablets delivered with 15 mL water (A), and 
crushed tablets delivered in 15 g thickened water (B, C). The crushed tablet was incorporated 
into the thickened water by manual (B) and mechanical mixing (C) with three different 
variants 1, 2 and 3. The data shows mean ± se for three replicates for dissolution tests 
performed in SGF at 37°C and 50 rpm. The lines in (B) and (C) are fits to the Korsmeyer-
Peppas model.  
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 Figure 2.  
Dissolution of acetaminophen from (A) effervescent tablet, (B) elixir, (C) suspension. 15 mL 
of medications were delivered straight from the bottle (B,C) or dissolved in water (A) (open 
symbols) or mixed with the quantity of thickener required to produce thickened water at level 
900 (filled symbols). The data shows mean ± se for three replicates for dissolution tests 
performed in SGF at 37°C and 50 rpm. The curves are fits to the Korsmeyer-Peppas model 
except for unthickened formulations in (A) and (B). 
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 Figure 3.  
Flow curves for dosage forms with (filled symbols) and without (open symbols) thickener at 
37°C using a vane tool. One representative flow curve from three replicates is shown. The 
unthickened effervescent tablet and elixir are not shown due to low viscosity (see Table 3) 
that did not change with shear stress. 
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 Figure 4.  
Mechanical spectrum of acetaminophen dosage forms thickened samples. Shown here are the 
elastic or storage modulus G’ (Pa) (filled symbols) and viscous or loss modulus, G” (Pa) 
(open symbols) as a function of frequency (𝑣) expressed in Hertz (cycles/sec) at 37°C, with a 
vane tool attachment for the A) effervescent tablet, B) elixir, C) suspension, D) crushed tablet 
and E) thickened water. The modulus with and without thickener are shown for the 
suspension; elixir and dissolved effervescent tablet exhibit constant viscosity. One 
representative sample from three replicates is presented. 
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 Table 1 
The percentage dissolution (mean ± standard error, n=3) in simulated gastric fluid at 30 
minutes for acetaminophen immediate release whole and crushed tablets delivered with 15 
mL of water and crushed tablets with 15 g of thickened water using two mixing methods 
(manual, mechanical) and three order of addition variants (1,2,3). Values of % dissolution 
with a different superscript letter are significantly different (P<0.05). Similarity factor (f2) 
with respect to the whole tablet and Kosmeyer-Peppas release exponent n (± se) and r
2
 (± se) 
were calculated. 
Formulation  % Dissolved at 
30 min 
Similarity  
factor f2 
Korsmeyer-Peppas 
n (se) r
2
 (se) 
Whole tablet 96.7 ± 1.3% 
a
    
Crushed tablet in: 
     Water 
     Thickened water 
 
98.3 ± 0.2% 
a
 
 
    
 Manual  
    Variant 1*     
    Variant 2 
    Variant 3    
Mechanical 
    Variant 1 
    Variant 2 
    Variant 3 
 
36.3 ± 2.8% 
bd
 
40.1 ± 2.3% 
b
 
35.3 ± 1.7%
 bd
 
 
26.8 ± 1.8% 
cd
 
24.9 ± 1.1% 
cd
 
21.6 ± 3.2% 
c
 
 
19.1 
20.5 
18.6 
 
15.4 
14.3 
13.0 
 
0.49 (0.018) 
0.41 (0.013) 
0.43 (0.028) 
 
0.47 (0.018) 
0.42 (0.014)  
0.42 (0.009) 
 
0.99 (2.18) 
0.99 (1.80) 
0.98 (3.44) 
 
0.99 (1.60) 
0.99 (1.33) 
0.99 (0.74) 
*Standard method used in clinical practice  
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 Table 2 
The percentage dissolution (mean ± standard error: n=3) in simulated gastric fluid at 30 
minutes for acetaminophen intact liquid dosage forms and with thickener added. Similarity 
factor (f2) of the thickened liquids with respect to the intact liquids and Kosmeyer-Peppas 
release exponent n (± se) and r
2
 (± se) were calculated. 
Formulation % Dissolved at 
30 min 
Similarity  
factor f2
 
Korsmeyer-Peppas 
n (se) r
2
 (se) 
Effervescent tablet 96.0 ± 2.1%    
Elixir  101.0 ± 3.1%    
Suspension 30.0 ± 1.3%  0.55 (0.040) 0.98 (4.81) 
Effervescent tablet + thickener 50.8 ± 2.9% 11.7 0.34 (0.026) 0.97 (4.63) 
Elixir + thickener 13.6 ± 0.7% 2.8 0.40 (0.013) 0.99 (0.68) 
Suspension + thickener 12.0 ± 4.2% 31.6 0.58 (0.021) 0.99 (0.74) 
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 Table 3 
 
Rheology of acetaminophen effervescent tablet, elixir and suspension with and without 
thickener added, measured at 37°C. Viscosity at 50 s
-1
 was interpolated from viscosity-shear 
rate data with standard error in brackets calculated from three replicate flow curves. Zero-
shear viscosity, infinite-shear viscosity and apparent yield stress values were extrapolated 
from one of the three replicate flow curves. 
Formulation Viscosity 
50 s
-1 
(Pas) 
Zero-shear 
viscosity 
n0 (Pas) 
Infinite-shear 
viscosity 
n∞ (Pas) 
Yield 
stress 
σy (Pa) 
Water 0.0009 (0.000)    
Effervescent tablet 0.008 (0.001)    
Elixir 0.015 (0.000)    
Suspension 0.403 (0.010) 357 0.403 2.7 
Effervescent tablet + thickener 1.540 (0.110) 17010 0.812 19 
Elixir + thickener 3.650 (0.450) 22923 2.542 26 
Suspension + thickener 4.380 (0.152) 114389 4.424 39 
Crushed tablet + thickener  0.625 (0.029) 16056 0.761 17 
Water + thickener 0.917 (0.095) 10982 0.626 14 
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